Proposed Rules Expand Exceptions from Healthcare Reform by Lori Oliphant Published on jdsupra.com
On December 24, 2013, the Departments of Treasury, Labor, and Health and Human Services (collectively, the “Departments”) jointly issued proposed rules that would expand the scope of arrangements that would constitute “excepted benefits” under the portability rules enacted by the Health Insurance Portability and Accountability Act (“HIPAA”)… [ Read More ]Sanofi to Pay $700 Million for Alnylam Drugs and Stake by Simeon Bennett Published on Bloomberg.com
Sanofi (SAN) agreed to pay $700 million for access to drugs developed by Alnylam Pharmaceuticals Inc. (ALNY) and a 12 percent stake in the biotechnology company, expanding its investments in treatments for rare genetic diseases… [ Read More ]M&A Boom Seen in 2014 as Drug Hunt Spurs Biotech Deals by Meg Tirrell and David Welch Published on Bloomberg.com
Health-care companies with deep pockets and shallow product pipelines are poised for a busy year of acquisitions, with biotechnology firms likely to be among the most prominent targets even as they trade at record highs… [ Read More ]Live Industry News
Follow @ACI_Pharma & @ACI_Health
Join ACI Pharmaceuticals/Biotech/Life Sciences Experts Group
Join ACI Healthcare: Legal, Regulatory, and Compliance Experts Group
Related Events
For the complete list of all Pharmaceuticals upcoming events: Click Here
For the complete list of all Healthcare upcoming events: Click Here
To download past Pharmaceuticals conference materials: Click Here
To download past Healthcare conference materials: Click Here